Test Code: *HYMDD+
Drug Resistance HBV genotyping (Lamivudine, Telbivudine, Adefovir, Entecavir Resistance Genotypes), Qualitative PCR, add-on with HBVQ
Hepatitis B virus (HBV) with drug resistance (DR) mutation is detected with PCR followed by hybridization and visualization on a membrane strip. The multipex PCR amplification targets on 5 hot spots of drug resistance associated mutations, namely rtM250V, rtA181V, rtN236T, rtM204l and rtM204V. Different combinations of these mutation hot spots are associated with antiviral drug Lamivudine, Telbivudine, Adefovir and Entecavir resistance.
Add-on test item. Repeat with same specimen from HBVQ test.
Turnaround Time :
Maximum to 3 days